Browse by author
Lookup NU author(s): Julie Doughty
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Objective. The goal of our work was to assess compliance and patient satisfaction with switching from sodium valproate to Depakine Chrono in patients with epilepsy. Methods. Clinical, demographic, and behavioral details assessing compliance and satisfaction were collected using self-completion questionnaires at the time of inclusion in the study and 3 months after the inclusion day. Results. Data were collected from 2031 respondents from eight European countries. There were significant differences between time 1 and time 2 of the study in seizure frequency, reported side effects, compliance, and patient satisfaction. Conclusion. Findings suggest that switching from sodium valproate to Depakine Chrono results in an increase in seizure-free rates, a reduction in reported side effects, an improvement in the level of compliance, and a modest improvement in patient satisfaction. © 2003 Elsevier Inc. All rights reserved.
Author(s): Doughty J, Baker GA, Jacoby A, Lavaud V
Publication type: Article
Publication status: Published
Journal: Epilepsy and Behavior
ISSN (print): 1525-5050
ISSN (electronic): 1525-5069
Publisher: Academic Press
PubMed id: 14698705
Altmetrics provided by Altmetric